Giustina A, Biermasz N, Casanueva FF, Fleseriu M, Mortini P, Strasburger C, van der Lely AJ, Wass J, Melmed S, Acromegaly Consensus Group (2024) Consensus on criteria for acromegaly diagnosis and remission. Pituitary 27(1):7–22. https://doi.org/10.1007/s11102-023-01360-1
Katznelson L, Laws ER Jr, Melmed S, Molitch ME, Murad MH, Utz A, Wass JA, Endocrine Society (2014) Acromegaly: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 99(11):3933–3951. https://doi.org/10.1210/jc.2014-2700
Colao A, Grasso LFS, Giustina A, Melmed S, Chanson P, Pereira AM, Pivonello R (2019) Acromegaly. Nat Rev Dis Primers 5(1):20. https://doi.org/10.1038/s41572-019-0071-6
Gadelha MR, Kasuki L, Lim DST, Fleseriu M (2019) Systemic complications of acromegaly and the impact of the current treatment landscape: an update. Endocr Rev 40(1):268–332. https://doi.org/10.1210/er.2018-00115
Bioletto F, Barale M, Prencipe N, Berton AM, Parasiliti-Caprino M, Gasco V, Ghigo E, Procopio M, Grottoli S (2023) Trabecular bone score as an index of bone fragility in patients with acromegaly: a systematic review and meta-analysis. Neuroendocrinology 113(4):395–405. https://doi.org/10.1159/000528199
Prencipe N, Scarati M, Manetta T, Berton AM, Parisi S, Bona C, Parasiliti-Caprino M, Ditto MC, Gasco V, Fusaro E, Grottoli S (2020) Acromegaly and joint pain: is there something more? A cross-sectional study to evaluate rheumatic disorders in growth hormone secreting tumor patients. J Endocrinol Invest 43(11):1661–1667. https://doi.org/10.1007/s40618-020-01268-8
Guaraldi F, Gori D, Beccuti G, Prencipe N, Giordano R, Mints Y, Di Giacomo VS, Berton A, Lorente M, Gasco V, Ghigo E, Salvatori R, Grottoli S (2016) Usefulness of an ad hoc questionnaire (Acro-CQ) for the systematic assessment of acromegaly comorbidities at diagnosis and their management at follow-up. J Endocrinol Invest 39(11):1277–1284. https://doi.org/10.1007/s40618-016-0476-y
Varaldo E, Prencipe N, Bona C, Cuboni D, Aversa LS, Sibilla M, Bioletto F, Berton AM, Gramaglia C, Gasco V, Ghigo E, Grottoli S (2024) Effect of Cabergoline on weight and glucose metabolism in patients with acromegaly. J Endocrinol Invest. https://doi.org/10.1007/s40618-024-02396-1
Article PubMed PubMed Central Google Scholar
Reid TJ, Post KD, Bruce JN, Nabi Kanibir M, Reyes-Vidal CM, Freda PU (2010) Features at diagnosis of 324 patients with acromegaly did not change from 1981 to 2006: acromegaly remains under-recognized and under-diagnosed. Clin Endocrinol (Oxf) 72(2):203–208. https://doi.org/10.1111/j.1365-2265.2009.03626.x
Dal J, Feldt-Rasmussen U, Andersen M, Kristensen LØ, Laurberg P, Pedersen L, Dekkers OM, Sørensen HT, Jørgensen JO (2016) Acromegaly incidence, prevalence, complications and long-term prognosis: a nationwide cohort study. Eur J Endocrinol 175(3):181–190. https://doi.org/10.1530/EJE-16-0117
Hoskuldsdottir GT, Fjalldal SB, Sigurjonsdottir HA (2015) The incidence and prevalence of acromegaly, a nationwide study from 1955 through 2013. Pituitary 18(6):803–807. https://doi.org/10.1007/s11102-015-0655-4
Caputo M, Ucciero A, Mele C, De Marchi L, Magnani C, Cena T, Marzullo P, Barone-Adesi F, Aimaretti G (2019) Use of administrative health databases to estimate incidence and prevalence of acromegaly in Piedmont Region, Italy. J Endocrinol Invest 42(4):397–402. https://doi.org/10.1007/s40618-018-0928-7
Raappana A, Koivukangas J, Ebeling T, Pirilä T (2010) Incidence of pituitary adenomas in Northern Finland in 1992–2007. J Clin Endocrinol Metab 95(9):4268–4275. https://doi.org/10.1210/jc.2010-0537
Daly AF, Rixhon M, Adam C, Dempegioti A, Tichomirowa MA, Beckers A (2006) High prevalence of pituitary adenomas: a cross-sectional study in the province of Liege, Belgium. J Clin Endocrinol Metab 91(12):4769–4775. https://doi.org/10.1210/jc.2006-1668
Fernandez A, Karavitaki N, Wass JA (2010) Prevalence of pituitary adenomas: a community-based, cross-sectional study in Banbury (Oxfordshire, UK). Clin Endocrinol (Oxf) 72(3):377–382. https://doi.org/10.1111/j.1365-2265.2009.03667.x
van der Lely AJ, Harris AG, Lamberts SW (1992) The sensitivity of growth hormone secretion to medical treatment in acromegalic patients: influence of age and sex. Clin Endocrinol (Oxf) 37(2):181–185. https://doi.org/10.1111/j.1365-2265.1992.tb02304.x
Minniti G, Esposito V, Piccirilli M, Fratticci A, Santoro A, Jaffrain-Rea ML (2005) Diagnosis and management of pituitary tumours in the elderly: a review based on personal experience and evidence of literature. Eur J Endocrinol 153(6):723–735. https://doi.org/10.1530/eje.1.02030
Jallad RS, Bronstein MD (2019) Acromegaly in the elderly patient. Arch Endocrinol Metab 63(6):638–645. https://doi.org/10.20945/2359-3997000000194
Article PubMed PubMed Central Google Scholar
Colao A, Amato G, Pedroncelli AM, Baldelli R, Grottoli S, Gasco V, Petretta M, Carella C, Pagani G, Tambura G, Lombardi G (2002) Gender- and age-related differences in the endocrine parameters of acromegaly. J Endocrinol Invest 25(6):532–538. https://doi.org/10.1007/BF03345496
Colao A, Pivonello R, Spinelli L, Galderisi M, Auriemma RS, Galdiero M, Vitale G, De Leo M, Lombardi G (2007) A retrospective analysis on biochemical parameters, cardiovascular risk and cardiomyopathy in elderly acromegalic patients. J Endocrinol Invest 30(6):497–506. https://doi.org/10.1007/BF03346334
Cuevas-Ramos D, Carmichael JD, Cooper O, Bonert VS, Gertych A, Mamelak AN, Melmed S (2015) A structural and functional acromegaly classification. J Clin Endocrinol Metab 100(1):122–131. https://doi.org/10.1210/jc.2014-2468.PMID:25250634;PMCID:PMC4283008
Petersenn S, Buchfelder M, Gerbert B, Franz H, Quabbe HJ, Schulte HM, Grussendorf M, Reincke M, Participants of the German Acromegaly Register (2009) Age and sex as predictors of biochemical activity in acromegaly: analysis of 1485 patients from the German Acromegaly Register. Clin Endocrinol (Oxf) 71(3):400–405. https://doi.org/10.1111/j.1365-2265.2009.03547.x
Tanimoto K, Hizuka N, Fukuda I, Takano K, Hanafusa T (2008) The influence of age on the GH-IGF1 axis in patients with acromegaly. Eur J Endocrinol 159(4):375–379. https://doi.org/10.1530/EJE-08-0243
Sarkar S, Chacko AG, Chacko G (2014) An analysis of granulation patterns, MIB-1 proliferation indices and p53 expression in 101 patients with acromegaly. Acta Neurochir (Wien) 156(12):2221–2230. https://doi.org/10.1007/s00701-014-2230-6. (discussion 2230)
Kiseljak-Vassiliades K, Carlson NE, Borges MT, Kleinschmidt-DeMasters BK, Lillehei KO, Kerr JM, Wierman ME (2015) Growth hormone tumor histological subtypes predict response to surgical and medical therapy. Endocrine 49(1):231–241. https://doi.org/10.1007/s12020-014-0383-y
Brzana J, Yedinak CG, Gultekin SH, Delashaw JB, Fleseriu M (2013) Growth hormone granulation pattern and somatostatin receptor subtype 2A correlate with postoperative somatostatin receptor ligand response in acromegaly: a large single center experience. Pituitary 16(4):490–498. https://doi.org/10.1007/s11102-012-0445-1
Berton AM, Prencipe N, Bertero L, Baldi M, Bima C, Corsico M, Bianchi A, Mantovani G, Ferraù F, Sartorato P, Gagliardi I, Ghigo E, Grottoli S (2022) Resistance to somatostatin analogs in Italian acromegaly patients: the MISS study. J Clin Med 12(1):25. https://doi.org/10.3390/jcm12010025
Article PubMed PubMed Central Google Scholar
Arita K, Hirano H, Yunoue S, Fujio S, Tominaga A, Sakoguchi T, Sugiyama K, Kurisu K (2008) Treatment of elderly acromegalics. Endocr J 55(5):895–903. https://doi.org/10.1507/endocrj.k08e-117
Akkus G, Odabaş F, Sözütok S, Sert M, Ak NE, Evran M, Tetiker T (2022) Novel classification of acromegaly in accordance with immunohistochemical subtypes: is there really a clinical relevance? Horm Metab Res 54(1):37–41. https://doi.org/10.1055/a-1685-0655
Swanson AA, Erickson D, Donegan DM, Jenkins SM, Van Gompel JJ, Atkinson JLD, Erickson BJ, Giannini C (2021) Clinical, biological, radiological, and pathological comparison of sparsely and densely
留言 (0)